Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer

Abstract Background Carbonic anhydrases catalyze CO2/HCO3 – buffer reactions with implications for effective H+ mobility, pH dynamics, and cellular acid–base sensing. Yet, the integrated consequences of carbonic anhydrases for cancer and stromal cell functions, their interactions, and patient progno...

Full description

Bibliographic Details
Main Authors: Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, Maria Sofia Espejo, Tina M. Pedersen, Marco Mele, Helene L. Pedersen, Eva Balling, Tonje Johansen, Mark Burton, Mads Thomassen, Pernille Vahl, Peer Christiansen, Ebbe Boedtkjer
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-023-01644-1
_version_ 1797836142038482944
author Soojung Lee
Nicolai J. Toft
Trine V. Axelsen
Maria Sofia Espejo
Tina M. Pedersen
Marco Mele
Helene L. Pedersen
Eva Balling
Tonje Johansen
Mark Burton
Mads Thomassen
Pernille Vahl
Peer Christiansen
Ebbe Boedtkjer
author_facet Soojung Lee
Nicolai J. Toft
Trine V. Axelsen
Maria Sofia Espejo
Tina M. Pedersen
Marco Mele
Helene L. Pedersen
Eva Balling
Tonje Johansen
Mark Burton
Mads Thomassen
Pernille Vahl
Peer Christiansen
Ebbe Boedtkjer
author_sort Soojung Lee
collection DOAJ
description Abstract Background Carbonic anhydrases catalyze CO2/HCO3 – buffer reactions with implications for effective H+ mobility, pH dynamics, and cellular acid–base sensing. Yet, the integrated consequences of carbonic anhydrases for cancer and stromal cell functions, their interactions, and patient prognosis are not yet clear. Methods We combine (a) bioinformatic analyses of human proteomic data and bulk and single-cell transcriptomic data coupled to clinicopathologic and prognostic information; (b) ex vivo experimental studies of gene expression in breast tissue based on quantitative reverse transcription and polymerase chain reactions, intracellular and extracellular pH recordings based on fluorescence confocal microscopy, and immunohistochemical protein identification in human and murine breast cancer biopsies; and (c) in vivo tumor size measurements, pH-sensitive microelectrode recordings, and microdialysis-based metabolite analyses in mice with experimentally induced breast carcinomas. Results Carbonic anhydrases—particularly the extracellular isoforms CA4, CA6, CA9, CA12, and CA14—undergo potent expression changes during human and murine breast carcinogenesis. In patients with basal-like/triple-negative breast cancer, elevated expression of the extracellular carbonic anhydrases negatively predicts survival, whereas, surprisingly, the extracellular carbonic anhydrases positively predict patient survival in HER2/ErbB2-enriched breast cancer. Carbonic anhydrase inhibition attenuates cellular net acid extrusion and extracellular H+ elimination from diffusion-restricted to peripheral and well-perfused regions of human and murine breast cancer tissue. Supplied in vivo, the carbonic anhydrase inhibitor acetazolamide acidifies the microenvironment of ErbB2-induced murine breast carcinomas, limits tumor immune infiltration (CD3+ T cells, CD19+ B cells, F4/80+ macrophages), lowers inflammatory cytokine (Il1a, Il1b, Il6) and transcription factor (Nfkb1) expression, and accelerates tumor growth. Supporting the immunomodulatory influences of carbonic anhydrases, patient survival benefits associated with high extracellular carbonic anhydrase expression in HER2-enriched breast carcinomas depend on the tumor inflammatory profile. Acetazolamide lowers lactate levels in breast tissue and blood without influencing breast tumor perfusion, suggesting that carbonic anhydrase inhibition lowers fermentative glycolysis. Conclusions We conclude that carbonic anhydrases (a) elevate pH in breast carcinomas by accelerating net H+ elimination from cancer cells and across the interstitial space and (b) raise immune infiltration and inflammation in ErbB2/HER2-driven breast carcinomas, restricting tumor growth and improving patient survival.
first_indexed 2024-04-09T15:05:00Z
format Article
id doaj.art-43eb9c61abb047289a64eb505c8ecf73
institution Directory Open Access Journal
issn 1465-542X
language English
last_indexed 2024-04-09T15:05:00Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Breast Cancer Research
spelling doaj.art-43eb9c61abb047289a64eb505c8ecf732023-04-30T11:32:16ZengBMCBreast Cancer Research1465-542X2023-04-0125112710.1186/s13058-023-01644-1Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancerSoojung Lee0Nicolai J. Toft1Trine V. Axelsen2Maria Sofia Espejo3Tina M. Pedersen4Marco Mele5Helene L. Pedersen6Eva Balling7Tonje Johansen8Mark Burton9Mads Thomassen10Pernille Vahl11Peer Christiansen12Ebbe Boedtkjer13Department of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityDepartment of Surgery, Randers Regional HospitalDepartment of Pathology, Randers Regional HospitalDepartment of Surgery, Randers Regional HospitalDepartment of Pathology, Randers Regional HospitalDepartment of Clinical Genetics, University of Southern DenmarkDepartment of Clinical Genetics, University of Southern DenmarkDepartment of Pathology, Aarhus University HospitalDepartment of Surgery, Randers Regional HospitalDepartment of Biomedicine, Aarhus UniversityAbstract Background Carbonic anhydrases catalyze CO2/HCO3 – buffer reactions with implications for effective H+ mobility, pH dynamics, and cellular acid–base sensing. Yet, the integrated consequences of carbonic anhydrases for cancer and stromal cell functions, their interactions, and patient prognosis are not yet clear. Methods We combine (a) bioinformatic analyses of human proteomic data and bulk and single-cell transcriptomic data coupled to clinicopathologic and prognostic information; (b) ex vivo experimental studies of gene expression in breast tissue based on quantitative reverse transcription and polymerase chain reactions, intracellular and extracellular pH recordings based on fluorescence confocal microscopy, and immunohistochemical protein identification in human and murine breast cancer biopsies; and (c) in vivo tumor size measurements, pH-sensitive microelectrode recordings, and microdialysis-based metabolite analyses in mice with experimentally induced breast carcinomas. Results Carbonic anhydrases—particularly the extracellular isoforms CA4, CA6, CA9, CA12, and CA14—undergo potent expression changes during human and murine breast carcinogenesis. In patients with basal-like/triple-negative breast cancer, elevated expression of the extracellular carbonic anhydrases negatively predicts survival, whereas, surprisingly, the extracellular carbonic anhydrases positively predict patient survival in HER2/ErbB2-enriched breast cancer. Carbonic anhydrase inhibition attenuates cellular net acid extrusion and extracellular H+ elimination from diffusion-restricted to peripheral and well-perfused regions of human and murine breast cancer tissue. Supplied in vivo, the carbonic anhydrase inhibitor acetazolamide acidifies the microenvironment of ErbB2-induced murine breast carcinomas, limits tumor immune infiltration (CD3+ T cells, CD19+ B cells, F4/80+ macrophages), lowers inflammatory cytokine (Il1a, Il1b, Il6) and transcription factor (Nfkb1) expression, and accelerates tumor growth. Supporting the immunomodulatory influences of carbonic anhydrases, patient survival benefits associated with high extracellular carbonic anhydrase expression in HER2-enriched breast carcinomas depend on the tumor inflammatory profile. Acetazolamide lowers lactate levels in breast tissue and blood without influencing breast tumor perfusion, suggesting that carbonic anhydrase inhibition lowers fermentative glycolysis. Conclusions We conclude that carbonic anhydrases (a) elevate pH in breast carcinomas by accelerating net H+ elimination from cancer cells and across the interstitial space and (b) raise immune infiltration and inflammation in ErbB2/HER2-driven breast carcinomas, restricting tumor growth and improving patient survival.https://doi.org/10.1186/s13058-023-01644-1AcetazolamideAcidosisBreast cancerCarbonic anhydrasesErbB2HER2
spellingShingle Soojung Lee
Nicolai J. Toft
Trine V. Axelsen
Maria Sofia Espejo
Tina M. Pedersen
Marco Mele
Helene L. Pedersen
Eva Balling
Tonje Johansen
Mark Burton
Mads Thomassen
Pernille Vahl
Peer Christiansen
Ebbe Boedtkjer
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
Breast Cancer Research
Acetazolamide
Acidosis
Breast cancer
Carbonic anhydrases
ErbB2
HER2
title Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
title_full Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
title_fullStr Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
title_full_unstemmed Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
title_short Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
title_sort carbonic anhydrases reduce the acidity of the tumor microenvironment promote immune infiltration decelerate tumor growth and improve survival in erbb2 her2 enriched breast cancer
topic Acetazolamide
Acidosis
Breast cancer
Carbonic anhydrases
ErbB2
HER2
url https://doi.org/10.1186/s13058-023-01644-1
work_keys_str_mv AT soojunglee carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT nicolaijtoft carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT trinevaxelsen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT mariasofiaespejo carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT tinampedersen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT marcomele carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT helenelpedersen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT evaballing carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT tonjejohansen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT markburton carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT madsthomassen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT pernillevahl carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT peerchristiansen carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer
AT ebbeboedtkjer carbonicanhydrasesreducetheacidityofthetumormicroenvironmentpromoteimmuneinfiltrationdeceleratetumorgrowthandimprovesurvivalinerbb2her2enrichedbreastcancer